ロード中...
Immunomodulatory activity of interferon-beta
Multiple sclerosis (MS) is a complex disorder of the central nervous system that appears to be driven by a shift in immune functioning toward excess inflammation that results in demyelination and axonal loss. Beta interferons were the first class of disease-modifying therapies to be approved for pat...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4184564/ https://ncbi.nlm.nih.gov/pubmed/25356432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.84 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|